10.31
3.81 (58.62%)
3.81 (58.62%)
Upgrade to Real-Time
Afterhours (Closed)
Low
0.17
High
18.77
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Ocugen Inc | OCGN | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 3.81 | 58.62% | 10.31 | 19:59:59 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 6.71 | 6.58 | 9.5474 | 9.29 | 6.50 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 10.27 | 10.31 | 0.04 | 1 | 2 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 678,416 | 231,428,682 | $ 7.51 | $ 1,739,005,799 | 86,724,407 | 0.17 - 18.77 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:59:59 | formt | 1,000 | $ 10.31 | USD |
Ocugen Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 1.67B | 162.03M | 156.81M | $ - | $ - | -8.42 | 0.60 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Ocugen News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical OCGN Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 6.86 | 9.55 | 5.2375 | 6.28 | 38,345,365 | 3.45 | 50.29% |
| 1 Month | 7.11 | 9.55 | 5.2375 | 6.64 | 26,343,707 | 3.20 | 45.01% |
| 3 Months | 1.595 | 18.77 | 1.595 | 9.14 | 58,980,643 | 8.72 | 546.39% |
| 6 Months | 0.32 | 18.77 | 0.2501 | 5.75 | 52,683,134 | 9.99 | 3,121.88% |
| 1 Year | 0.40 | 18.77 | 0.17 | 4.21 | 36,276,057 | 9.91 | 2,477.5% |
| 3 Years | 3.24 | 18.77 | 0.17 | 3.98 | 24,924,171 | 7.07 | 218.21% |
| 5 Years | 3.24 | 18.77 | 0.17 | 3.98 | 24,924,171 | 7.07 | 218.21% |
Ocugen Description
| Ocugen Inc is a clinical-stage biopharmaceutical company. It is focused on discovering, developing and commercializing a pipeline of innovative therapies that address rare and underserved eye diseases. Ocugen offers a diversified ophthalmology portfolio that includes novel gene therapies, biologics, and small molecules and targets a broad range of high-need retinal and ocular surface diseases. Its product candidate includes OCU200 and OCU300 to treat diabetic macular edema (DME), diabetic retinopathy (DR) and wet age-related macular degeneration (AMD). |
